{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:49:51Z","timestamp":1733896191076,"version":"3.30.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00108-024-01794-0","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T20:50:33Z","timestamp":1727297433000},"page":"1199-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Was ist gesichert in der Therapie der Sepsis?","What is confirmed in the treatment of sepsis?"],"prefix":"10.1007","volume":"65","author":[{"given":"Uta","family":"Hillebrand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Rex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Seeliger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"issue":"12","key":"1794_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s00108-020-00895-w","volume":"61","author":"K Stahl","year":"2020","unstructured":"Stahl\u00a0K, Seeliger\u00a0B, David\u00a0S, Schmidt\u00a0J (2020) Was ist gesichert in der Therapie der Sepsis? Internist 61(12):1238\u20131248","journal-title":"Internist"},{"issue":"8","key":"1794_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer\u00a0M, Deutschman\u00a0CS, Seymour\u00a0CW, Shankar-Hari\u00a0M, Annane\u00a0D, Bauer\u00a0M et\u00a0al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801","journal-title":"JAMA"},{"issue":"9","key":"1794_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus\u00a0DC, van der Poll\u00a0T (2013) Severe sepsis and septic shock. N\u00a0Engl J Med 369(9):840\u2013851","journal-title":"N Engl J Med"},{"issue":"S2","key":"1794_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00063-020-00685-0","volume":"115","author":"FM Brunkhorst","year":"2020","unstructured":"Deutsche Sepsis Gesellschaft e.V., Brunkhorst\u00a0FM, Weigand\u00a0MA, Pletz\u00a0M, Gastmeier\u00a0P, Lemmen\u00a0SW (2020) S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge: Langfassung. Med Klin Intensivmed Notfmed 115(S2):37\u2013109","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"11","key":"1794_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans\u00a0L, Rhodes\u00a0A, Alhazzani\u00a0W, Antonelli\u00a0M, Coopersmith\u00a0CM, French\u00a0C et\u00a0al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47(11):1181\u20131247","journal-title":"Intensive Care Med"},{"issue":"4","key":"1794_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M17-3415","volume":"168","author":"M Singer","year":"2018","unstructured":"Singer\u00a0M, Shankar-Hari\u00a0M (2018) qSOFA, cue confusion. Ann Intern Med 168(4):293","journal-title":"Ann Intern Med"},{"key":"1794_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/nicc.13016","author":"L Lan","year":"2023","unstructured":"Lan\u00a0L, Zhou\u00a0M, Chen\u00a0X, Dai\u00a0M, Wang\u00a0L, Li\u00a0H (2023) Prognostic accuracy of SOFA , MEWS , and SIRS criteria in predicting the mortality rate of patients with sepsis: a\u00a0meta-analysis. Nurs Crit Care. https:\/\/doi.org\/10.1111\/nicc.13016","journal-title":"Nurs Crit Care"},{"issue":"4","key":"1794_CR8","first-page":"158","volume":"76","author":"SW van der Woude","year":"2018","unstructured":"van der Woude\u00a0SW, van Doormaal\u00a0FF, Hutten\u00a0BA, Nellen\u00a0JF, Holleman\u00a0F (2018) Classifying sepsis patients in the emergency department using SIRS, qSOFA or MEWS. Neth J Med 76(4):158\u2013166","journal-title":"Neth J Med"},{"issue":"7","key":"1794_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong\u00a0E, van Oers\u00a0JA, Beishuizen\u00a0A, Vos\u00a0P, Vermeijden\u00a0WJ, Haas\u00a0LE et\u00a0al (2016) Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a\u00a0randomised, controlled, open-label trial. Lancet Infect Dis 16(7):819\u2013827","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1794_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1472-6963-13-322","volume":"13","author":"NM Redmond","year":"2013","unstructured":"Redmond\u00a0NM, Davies\u00a0R, Christensen\u00a0H, Blair\u00a0PS, Lovering\u00a0AM, Leeming\u00a0JP et\u00a0al (2013) The TARGET cohort study protocol: a\u00a0prospective primary care cohort study to derive and validate a\u00a0clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Serv Res 13(1):322","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"1794_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/antibiotics12071112","volume":"12","author":"U Chiriac","year":"2023","unstructured":"Chiriac\u00a0U, Richter\u00a0D, Frey\u00a0OR, R\u00f6hr\u00a0AC, Helbig\u00a0S, Hagel\u00a0S et\u00a0al (2023) Software- and TDM-guided dosing of meropenem promises high rates of target attainment in critically ill patients. Antibiotics 12(7):1112","journal-title":"Antibiotics"},{"issue":"1","key":"1794_CR12","doi-asserted-by":"publisher","first-page":"e0244966","DOI":"10.1371\/journal.pone.0244966","volume":"16","author":"P Thabet","year":"2021","unstructured":"Thabet\u00a0P, Joshi\u00a0A, MacDonald\u00a0E, Hutton\u00a0B, Cheng\u00a0W, Stevens\u00a0A et\u00a0al (2021) Clinical and pharmacokinetic\/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: an overview of systematic reviews. PLoS ONE 16(1):e244966","journal-title":"PLoS ONE"},{"issue":"2","key":"1794_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.2023.10598","volume":"330","author":"G Monti","year":"2023","unstructured":"Monti\u00a0G, Bradi\u0107\u00a0N, Marzaroli\u00a0M, Konkayev\u00a0A, Fominskiy\u00a0E, Kotani\u00a0Y et\u00a0al (2023) Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial. JAMA 330(2):141","journal-title":"JAMA"},{"key":"1794_CR14","doi-asserted-by":"crossref","unstructured":"Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO et\u00a0al (2024) Continuous vs intermittent \u03b2\u2011lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2819971. Zugegriffen: 18. Aug. 2024","DOI":"10.1001\/jama.2024.9779"},{"issue":"15","key":"1794_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi\u00a0P, Tognoni\u00a0G, Masson\u00a0S, Fumagalli\u00a0R, Pesenti\u00a0A, Romero\u00a0M et\u00a0al (2014) Albumin replacement in patients with severe sepsis or septic shock. N\u00a0Engl J Med 370(15):1412\u20131421","journal-title":"N Engl J Med"},{"issue":"2","key":"1794_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1742-6723.13394","volume":"32","author":"A Delaney","year":"2020","unstructured":"Delaney\u00a0A, Finnis\u00a0M, Bellomo\u00a0R, Udy\u00a0A, Jones\u00a0D, Keijzers\u00a0G et\u00a0al (2020) Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a\u00a0retrospective cohort study. Emerg Med Australas 32(2):210\u2013219","journal-title":"Emerg Med Australas"},{"issue":"4","key":"1794_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.chest.2023.10.027","volume":"165","author":"ES Munroe","year":"2024","unstructured":"Munroe\u00a0ES, Heath\u00a0ME, Eteer\u00a0M, Gershengorn\u00a0HB, Horowitz\u00a0JK, Jones\u00a0J et\u00a0al (2024) Use and outcomes of peripheral vasopressors in early sepsis-induced hypotension across Michigan hospitals. Chest 165(4):847\u2013857","journal-title":"Chest"},{"issue":"5","key":"1794_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon\u00a0AC, Mason\u00a0AJ, Thirunavukkarasu\u00a0N, Perkins\u00a0GD, Cecconi\u00a0M, Cepkova\u00a0M et\u00a0al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316(5):509","journal-title":"JAMA"},{"key":"1794_CR19","doi-asserted-by":"crossref","unstructured":"Gordon AC, Santhakumaran S, Al-Beidh F, Orme RM, Perkins GD, Singer M et\u00a0al (2018) Levosimendan to prevent acute organ dysfunction in sepsis: the LeoPARDS RCT. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK533044\/. Zugegriffen: 18. Aug. 2024","DOI":"10.3310\/eme05060"},{"issue":"1","key":"1794_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0885066620972943","volume":"37","author":"SE Smith","year":"2022","unstructured":"Smith\u00a0SE, Newsome\u00a0AS, Guo\u00a0Y, Hecht\u00a0J, McCurdy\u00a0MT, Mazzeffi\u00a0MA et\u00a0al (2022) A\u00a0multicenter observational cohort study of angiotensin\u00a0II in shock. J\u00a0Intensive Care Med 37(1):75\u201382","journal-title":"J Intensive Care Med"},{"issue":"5","key":"1794_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","volume":"18","author":"LS Chawla","year":"2014","unstructured":"Chawla\u00a0LS, Busse\u00a0L, Brasha-Mitchell\u00a0E, Davison\u00a0D, Honiq\u00a0J, Alotaibi\u00a0Z et\u00a0al (2014) Intravenous angiotensin\u00a0II for the treatment of high-output shock (ATHOS trial): a\u00a0pilot study. Crit Care 18(5):534","journal-title":"Crit Care"},{"issue":"19","key":"1794_CR22","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"E Rivers","year":"2001","unstructured":"Rivers\u00a0E, Nguyen\u00a0B, Havstad\u00a0S, Ressler\u00a0J, Muzzin\u00a0A, Knoblich\u00a0B et\u00a0al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N\u00a0Engl J Med 345(19):1368\u20131377","journal-title":"N Engl J Med"},{"issue":"18","key":"1794_CR23","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","volume":"370","author":"The ProCESS Investigators","year":"2014","unstructured":"The ProCESS Investigators (2014) A\u00a0randomized trial of protocol-based care for early septic shock. N\u00a0Engl J Med 370(18):1683\u20131693","journal-title":"N Engl J Med"},{"issue":"16","key":"1794_CR24","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","volume":"371","author":"he ARISE Investigators and the ANZICS Clinical Trials Group","year":"2014","unstructured":"he ARISE Investigators and the ANZICS Clinical Trials Group (2014) Goal-directed resuscitation for patients with early septic shock. N\u00a0Engl J Med 371(16):1496\u20131506","journal-title":"N Engl J Med"},{"issue":"97","key":"1794_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19970","volume":"19","author":"PR Mouncey","year":"2015","unstructured":"Mouncey\u00a0PR, Osborn\u00a0TM, Power\u00a0GS, Harrison\u00a0DA, Sadique\u00a0MZ, Grieve\u00a0RD et\u00a0al (2015) Protocolised management in sepsis (proMIse): a\u00a0multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock. Health Technol Assess 19(97):1\u2013150","journal-title":"Health Technol Assess"},{"issue":"26","key":"1794_CR26","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","volume":"386","author":"TS Meyhoff","year":"2022","unstructured":"Meyhoff\u00a0TS, Hjortrup\u00a0PB, Wetterslev\u00a0J, Sivapalan\u00a0P, Laake\u00a0JH, Cronhjort\u00a0M et\u00a0al (2022) Restriction of intravenous fluid in ICU patients with septic shock. N\u00a0Engl J Med 386(26):2459\u20132470","journal-title":"N Engl J Med"},{"issue":"6","key":"1794_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJMoa2212663","volume":"388","author":"The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network","year":"2023","unstructured":"The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network (2023) Early restrictive or liberal fluid management for sepsis-induced hypotension. N\u00a0Engl J Med 388(6):499\u2013510","journal-title":"N Engl J Med"},{"issue":"1","key":"1794_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13613-019-0528-5","volume":"9","author":"Y Jouan","year":"2019","unstructured":"Jouan\u00a0Y, Seegers\u00a0V, Meziani\u00a0F, Grelon\u00a0F, Megarbane\u00a0B, Anguel\u00a0N et\u00a0al (2019) Effects of mean arterial pressure on arousal in sedated ventilated patients with septic shock: a\u00a0SEPSISPAM post hoc exploratory study. Ann Intensive Care 9(1):54","journal-title":"Ann Intensive Care"},{"issue":"2","key":"1794_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jhep.2023.04.006","volume":"79","author":"R Maiwall","year":"2023","unstructured":"Maiwall\u00a0R, Rao Pasupuleti\u00a0SS, Hidam\u00a0AK, Kumar\u00a0A, Tevethia\u00a0HV, Vijayaraghavan\u00a0R et\u00a0al (2023) A\u00a0randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock. J\u00a0Hepatol 79(2):349\u2013361","journal-title":"J Hepatol"},{"issue":"10","key":"1794_CR30","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00134-015-3955-2","volume":"41","author":"WJ Gu","year":"2015","unstructured":"Gu\u00a0WJ, Zhang\u00a0Z, Bakker\u00a0J (2015) Early lactate clearance-guided therapy in patients with sepsis: a\u00a0meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med 41(10):1862\u20131863","journal-title":"Intensive Care Med"},{"issue":"7","key":"1794_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez\u00a0G, Ospina-Tasc\u00f3n\u00a0GA, Damiani\u00a0LP, Estenssoro\u00a0E, Dubin\u00a0A, Hurtado\u00a0J et\u00a0al (2019) Effect of a\u00a0resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA 321(7):654","journal-title":"JAMA"},{"issue":"2","key":"1794_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000520294","volume":"101","author":"J Gottlieb","year":"2022","unstructured":"Gottlieb\u00a0J, Capetian\u00a0P, Hamsen\u00a0U, Janssens\u00a0U, Karagiannidis\u00a0C, Kluge\u00a0S et\u00a0al (2022) German S3 guideline: oxygen therapy in the acute care of adult patients. Respiration 101(2):214\u2013252","journal-title":"Respiration"},{"issue":"23","key":"1794_CR33","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"JP Frat","year":"2015","unstructured":"Frat\u00a0JP, Thille\u00a0AW, Mercat\u00a0A, Girault\u00a0C, Ragot\u00a0S, Perbet\u00a0S et\u00a0al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N\u00a0Engl J Med 372(23):2185\u20132196","journal-title":"N Engl J Med"},{"issue":"7","key":"1794_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","volume":"49","author":"G Grasselli","year":"2023","unstructured":"Grasselli\u00a0G, Calfee\u00a0CS, Camporota\u00a0L, Poole\u00a0D, Amato\u00a0MBP, Antonelli\u00a0M et\u00a0al (2023) ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 49(7):727\u2013759","journal-title":"Intensive Care Med"},{"issue":"21","key":"1794_CR35","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes\u00a0A, Hajage\u00a0D, Capellier\u00a0G, Demoule\u00a0A, Lavou\u00e9\u00a0S, Guervilly\u00a0C et\u00a0al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N\u00a0Engl J Med 378(21):1965\u20131975","journal-title":"N Engl J Med"},{"issue":"9698","key":"1794_CR36","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","volume":"374","author":"GJ Peek","year":"2009","unstructured":"Peek\u00a0GJ, Mugford\u00a0M, Tiruvoipati\u00a0R, Wilson\u00a0A, Allen\u00a0E, Thalanany\u00a0MM et\u00a0al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a\u00a0multicentre randomised controlled trial. Lancet 374(9698):1351\u20131363","journal-title":"Lancet"},{"issue":"15","key":"1794_CR37","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1056\/NEJMoa2024922","volume":"384","author":"CG Hughes","year":"2021","unstructured":"Hughes\u00a0CG, Mailloux\u00a0PT, Devlin\u00a0JW, Swan\u00a0JT, Sanders\u00a0RD, Anzueto\u00a0A et\u00a0al (2021) Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N\u00a0Engl J Med 384(15):1424\u20131436","journal-title":"N Engl J Med"},{"issue":"2","key":"1794_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/08998280.2021.1997063","volume":"35","author":"B Abdelazeem","year":"2022","unstructured":"Abdelazeem\u00a0B, Malik\u00a0B, Mohamed\u00a0MMG, Savarapu\u00a0P, Isa\u00a0S, Kheiri\u00a0B et\u00a0al (2022) Meta-analysis comparing dexmedetomidine versus standard of care for sedation in patients with sepsis. Bayl Univ Med Cent Proc 35(2):184\u2013189","journal-title":"Bayl Univ Med Cent Proc"},{"issue":"7","key":"1794_CR39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1164\/rccm.202206-1208OC","volume":"207","author":"Y Shehabi","year":"2023","unstructured":"Shehabi\u00a0Y, Serpa Neto\u00a0A, Bellomo\u00a0R, Howe\u00a0BD, Arabi\u00a0YM, Bailey\u00a0M et\u00a0al (2023) Dexmedetomidine and propofol sedation in critically ill patients and dose-associated 90-day mortality: a\u00a0secondary cohort analysis of a\u00a0randomized controlled trial (SPICE III). Am J Respir Crit Care Med 207(7):876\u2013886","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"1794_CR40","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","volume":"298","author":"PP Pandharipande","year":"2007","unstructured":"Pandharipande\u00a0PP, Pun\u00a0BT, Herr\u00a0DL, Maze\u00a0M, Girard\u00a0TD, Miller\u00a0RR et\u00a0al (2007) Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 298(22):2644","journal-title":"JAMA"},{"issue":"8","key":"1794_CR41","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste\u00a0EAJ, Bagshaw\u00a0SM, Bellomo\u00a0R, Cely\u00a0CM, Colman\u00a0R, Cruz\u00a0DN et\u00a0al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411\u20131423","journal-title":"Intensive Care Med"},{"key":"1794_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4891","author":"JT Poston","year":"2019","unstructured":"Poston\u00a0JT, Koyner\u00a0JL (2019) Sepsis associated acute kidney injury. BMJ. https:\/\/doi.org\/10.1136\/bmj.k4891","journal-title":"BMJ"},{"issue":"5","key":"1794_CR43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana\u00a0S, Manrique-Caballero\u00a0CL, G\u00f3mez\u00a0H, Kellum\u00a0JA (2019) Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96(5):1083\u20131099","journal-title":"Kidney Int"},{"issue":"3","key":"1794_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa2000741","volume":"383","author":"The STARRT-AKI Investigators","year":"2020","unstructured":"The STARRT-AKI Investigators (2020) Timing of initiation of renal-replacement therapy in acute kidney injury. N\u00a0Engl J Med 383(3):240\u2013251","journal-title":"N Engl J Med"},{"issue":"15","key":"1794_CR45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","volume":"379","author":"SD Barbar","year":"2018","unstructured":"Barbar\u00a0SD, Clere-Jehl\u00a0R, Bourredjem\u00a0A, Hernu\u00a0R, Montini\u00a0F, Bruy\u00e8re\u00a0R et\u00a0al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N\u00a0Engl J Med 379(15):1431\u20131442","journal-title":"N Engl J Med"},{"issue":"10281","key":"1794_CR46","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(21)00350-0","volume":"397","author":"S Gaudry","year":"2021","unstructured":"Gaudry\u00a0S, Hajage\u00a0D, Martin-Lefevre\u00a0L, Lebbah\u00a0S, Louis\u00a0G, Moschietto\u00a0S et\u00a0al (2021) Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI\u00a02): a\u00a0multicentre, open-label, randomised, controlled trial. Lancet 397(10281):1293\u20131300","journal-title":"Lancet"},{"issue":"7","key":"1794_CR47","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/ndt\/gfp035","volume":"24","author":"R Faulhaber-Walter","year":"2009","unstructured":"Faulhaber-Walter\u00a0R, Hafer\u00a0C, Jahr\u00a0N, Vahlbruch\u00a0J, Hoy\u00a0L, Haller\u00a0H et\u00a0al (2009) The Hannover dialysis outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 24(7):2179\u20132186","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"1794_CR48","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","volume":"39","author":"O Joannes-Boyau","year":"2013","unstructured":"Joannes-Boyau\u00a0O, Honor\u00e9\u00a0PM, Perez\u00a0P, Bagshaw\u00a0SM, Grand\u00a0H, Canivet\u00a0JL et\u00a0al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a\u00a0multicentre randomized controlled trial. Intensive Care Med 39(9):1535\u20131546","journal-title":"Intensive Care Med"},{"issue":"17","key":"1794_CR49","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"RENAL Replacement Therapy Study Investigators","year":"2009","unstructured":"RENAL Replacement Therapy Study Investigators (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N\u00a0Engl J Med 361(17):1627\u20131638","journal-title":"N Engl J Med"},{"issue":"10141","key":"1794_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","volume":"392","author":"S Jaber","year":"2018","unstructured":"Jaber\u00a0S, Paugam\u00a0C, Futier\u00a0E, Lefrant\u00a0JY, Lasocki\u00a0S, Lescot\u00a0T et\u00a0al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a\u00a0multicentre, open-label, randomised controlled, phase\u00a03\u00a0trial. Lancet 392(10141):31\u201340","journal-title":"Lancet"},{"key":"1794_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07531-3","author":"PM Honor\u00e9","year":"2024","unstructured":"Honor\u00e9\u00a0PM, Rimmel\u00e9\u00a0T, Joannes-Boyau\u00a0O (2024) Citrate anticoagulation for continuous renal replacement therapy. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-024-07531-3","journal-title":"Intensive Care Med"},{"issue":"1","key":"1794_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40635-023-00592-6","volume":"12","author":"K Stahl","year":"2024","unstructured":"Stahl\u00a0K, Bode\u00a0C, Seeliger\u00a0B, Wendel-Garcia\u00a0PD, David\u00a0S (2024) Current clinical practice in using adjunctive extracorporeal blood purification in sepsis and septic shock: results from the ESICM \u201cEXPLORATION\u201d survey. Intensive Care Med Exp 12(1):5","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"1794_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13054-023-04492-9","volume":"27","author":"S Becker","year":"2023","unstructured":"Becker\u00a0S, Lang\u00a0H, Vollmer Barbosa\u00a0C, Tian\u00a0Z, Melk\u00a0A, Schmidt\u00a0BMW (2023) Efficacy of CytoSorb\u00ae: a\u00a0systematic review and meta-analysis. Crit Care 27(1):215","journal-title":"Crit Care"},{"issue":"3","key":"1794_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00134-020-06339-1","volume":"47","author":"S David","year":"2021","unstructured":"David\u00a0S, Bode\u00a0C, Putensen\u00a0C, Welte\u00a0T, Stahl\u00a0K (2021) Adjuvant therapeutic plasma exchange in septic shock. Intensive Care Med 47(3):352\u2013354","journal-title":"Intensive Care Med"},{"issue":"1","key":"1794_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13063-023-07300-5","volume":"24","author":"S David","year":"2023","unstructured":"David\u00a0S, Bode\u00a0C, Stahl\u00a0K (2023) EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock\u2014a study protocol for a\u00a0randomized, prospective, multicenter, open-label, controlled, parallel-group trial. Trials 24(1):277","journal-title":"Trials"},{"issue":"1","key":"1794_CR56","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13054-023-04719-9","volume":"27","author":"M Singer","year":"2023","unstructured":"Singer\u00a0M, Torres\u00a0A, Heinz\u00a0CC, Wei\u00dfm\u00fcller\u00a0S, Staus\u00a0A, Kistner\u00a0S et\u00a0al (2023) The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a\u00a0post hoc analysis of the phase\u00a0II CIGMA trial. Crit Care 27(1):436","journal-title":"Crit Care"},{"issue":"9","key":"1794_CR57","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/cid\/ciy401","volume":"67","author":"T Parks","year":"2018","unstructured":"Parks\u00a0T, Wilson\u00a0C, Curtis\u00a0N, Norrby-Teglund\u00a0A, Sriskandan\u00a0S (2018) Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a\u00a0systematic review and meta-analysis. Clin Infect Dis 67(9):1434\u20131436","journal-title":"Clin Infect Dis"},{"key":"1794_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001090.pub2","author":"MM Alejandria","year":"2024","unstructured":"Alejandria\u00a0MM, Lansang\u00a0MAD, Dans\u00a0LF, Mantaring Iii\u00a0JB (2024) Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001090.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"1794_CR59","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh\u00a0B, Finfer\u00a0S, Cohen\u00a0J, Rajbhandari\u00a0D, Arabi\u00a0Y, Bellomo\u00a0R et\u00a0al (2018) Adjunctive glucocorticoid therapy in patients with septic shock. N\u00a0Engl J Med 378(9):797\u2013808","journal-title":"N Engl J Med"},{"issue":"9","key":"1794_CR60","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane\u00a0D, Renault\u00a0A, Brun-Buisson\u00a0C, Megarbane\u00a0B, Quenot\u00a0JP, Siami\u00a0S et\u00a0al (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. N\u00a0Engl J Med 378(9):809\u2013818","journal-title":"N Engl J Med"},{"issue":"10","key":"1794_CR61","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","volume":"209","author":"B Teja","year":"2024","unstructured":"Teja\u00a0B, Berube\u00a0M, Pereira\u00a0TV, Law\u00a0AC, Schanock\u00a0C, Pang\u00a0B et\u00a0al (2024) Effectiveness of fludrocortisone plus hydrocortisone versus hydrocortisone alone in septic shock: a\u00a0systematic review and network meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 209(10):1219\u20131228","journal-title":"Am J Respir Crit Care Med"},{"key":"1794_CR62","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300034","author":"R Pirracchio","year":"2023","unstructured":"Pirracchio\u00a0R, Annane\u00a0D, Waschka\u00a0AK, Lamontagne\u00a0F, Arabi\u00a0YM, Bollaert\u00a0PE et\u00a0al (2023) Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock. NEJM Evid. https:\/\/doi.org\/10.1056\/EVIDoa2300034","journal-title":"NEJM Evid"},{"issue":"5","key":"1794_CR63","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S2213-2600(23)00430-7","volume":"12","author":"N Heming","year":"2024","unstructured":"Heming\u00a0N, Renault\u00a0A, Kuperminc\u00a0E, Brun-Buisson\u00a0C, Megarbane\u00a0B, Quenot\u00a0JP et\u00a0al (2024) Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a\u00a0subgroup analysis of the APROCCHSS phase\u00a03 randomised trial. Lancet Respir Med 12(5):366\u2013374","journal-title":"Lancet Respir Med"},{"issue":"7","key":"1794_CR64","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00134-015-3840-z","volume":"41","author":"S Beitland","year":"2015","unstructured":"Beitland\u00a0S, Sandven\u00a0I, Kj\u00e6rvik\u00a0LK, Sandset\u00a0PM, Sunde\u00a0K, Eken\u00a0T (2015) Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a\u00a0systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 41(7):1209\u20131219","journal-title":"Intensive Care Med"},{"key":"1794_CR65","doi-asserted-by":"publisher","first-page":"857368","DOI":"10.3389\/fpubh.2022.857368","volume":"10","author":"Z Lu","year":"2022","unstructured":"Lu\u00a0Z, Tao\u00a0G, Sun\u00a0X, Zhang\u00a0Y, Jiang\u00a0M, Liu\u00a0Y et\u00a0al (2022) Association of blood glucose level and glycemic variability with mortality in sepsis patients during ICU hospitalization. Front Public Health 10:857368","journal-title":"Front Public Health"},{"issue":"1","key":"1794_CR66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","volume":"38","author":"P Singer","year":"2019","unstructured":"Singer\u00a0P, Blaser\u00a0AR, Berger\u00a0MM, Alhazzani\u00a0W, Calder\u00a0PC, Casaer\u00a0MP et\u00a0al (2019) ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 38(1):48\u201379","journal-title":"Clin Nutr"},{"key":"1794_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6722","author":"Z Ye","year":"2020","unstructured":"Ye\u00a0Z, Reintam Blaser\u00a0A, Lytvyn\u00a0L, Wang\u00a0Y, Guyatt\u00a0GH, Mikita\u00a0JS et\u00a0al (2020) Gastrointestinal bleeding prophylaxis for critically ill patients: a\u00a0clinical practice guideline. BMJ. https:\/\/doi.org\/10.1136\/bmj.l6722","journal-title":"BMJ"},{"issue":"23","key":"1794_CR68","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1056\/NEJMoa1714919","volume":"379","author":"M Krag","year":"2018","unstructured":"Krag\u00a0M, Marker\u00a0S, Perner\u00a0A, Wetterslev\u00a0J, Wise\u00a0MP, Schefold\u00a0JC et\u00a0al (2018) Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N\u00a0Engl J Med 379(23):2199\u20132208","journal-title":"N Engl J Med"},{"issue":"6","key":"1794_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.5144\/0256-4947.2016.427","volume":"36","author":"W Alhazzani","year":"2016","unstructured":"Alhazzani\u00a0W, Guyatt\u00a0G, Marshall\u00a0JC, Hall\u00a0R, Muscedere\u00a0J, Lauzier\u00a0F et\u00a0al (2016) Re-evaluating the inhibition of stress erosions (REVISE): a\u00a0protocol for pilot randomized controlled trial. Ann Saudi Med 36(6):427\u2013433","journal-title":"Ann Saudi Med"},{"issue":"25","key":"1794_CR70","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","volume":"386","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne\u00a0F, Masse\u00a0MH, Menard\u00a0J, Sprague\u00a0S, Pinto\u00a0R, Heyland\u00a0DK et\u00a0al (2022) Intravenous vitamin\u00a0C in adults with sepsis in the intensive care unit. N\u00a0Engl J Med 386(25):2387\u20132398","journal-title":"N Engl J Med"},{"issue":"5","key":"1794_CR71","doi-asserted-by":"publisher","first-page":"e000018","DOI":"10.1136\/esmoopen-2015-000018","volume":"1","author":"P Schellongowski","year":"2016","unstructured":"Schellongowski\u00a0P, Sperr\u00a0WR, Wohlfarth\u00a0P, Knoebl\u00a0P, Rabitsch\u00a0W, Watzke\u00a0HH et\u00a0al (2016) Critically ill patients with cancer: chances and limitations of intensive care medicine\u2014a narrative review. ESMO Open 1(5):e18","journal-title":"ESMO Open"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01794-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01794-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01794-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:03:11Z","timestamp":1733868191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01794-0"}},"subtitle":["Ein Update","An update"],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1794"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01794-0","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"30 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Hillebrand, N.\u00a0Rex, B.\u00a0Seeliger, K.\u00a0Stahl und H.\u00a0Schenk geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}